NAA Services for Anti-E Antibody

Thalassemia is a major health problem in many areas. Red blood cell (RBC) alloimmunization is an important complication in transfusion-dependent patients. Transfusion of leukoreduced and phenotypically matched cells for selective antigens may help reduce expenses and risks of alloimmunization in patients with thalassemia. As an acknowledged natural autoantibody (NAA) service provider, Creative Biolabs can offer various NAA-related services against anti-E autoantibody to help our worldwide customers obtain progress. We can save your valuable time but also provide highly sensitive and qualified services.

Background of Anti-E Antibody

Before the transfusion of the RBCs is applied, pre-transfusion testing such as ABO, Rh and Kell blood grouping with a negative cross-match is obligatory. Anti-E is the most common and important RBC alloantibody in the Chinese population. Being a less potent immunogen, clinical manifestations of anti-E alloimmunization are more variable. Anti-E alloimmunization can cause hemolytic disease of the fetus or newborn requiring prenatal intervention. In addition, anti-E antibodies are one of the most commonly implicated non-D Rhesus antibodies in the pathogenesis of hemolytic diseases of the newborn.

The Role of Anti-E Antibody in Thalassemia

To correct anemia in the β-thalassemia patients, regular blood transfusion regimen every 3-4 weeks is recommended that may lead to alloimmunization to erythrocyte antigens. Development of RBC alloantibodies and autoantibodies may complicate transfusion therapy. Some alloantibodies are hemolytic and may cause hemolytic transfusion reactions and limit the availability of compatible RBC units for transfusions. In numerous studies, the most frequently detected alloantibodies belong to Rh blood group system (52.17%). Individually, most frequent alloantibodies were anti-Kell (35%) and anti-E (17%).

Fig.1 Ineffective erythropoiesis in β-thalassaemia. (Longo, et al., 2021)Fig.1 Mechanisms of ineffective erythropoiesis in β-thalassaemia.1

What We Can Do About NAA?

Based on our well-established platforms and experienced scientists, we can provide comprehensive NAA services, including but not limited to NAA detection, NAA profiling, and NAA epitope mapping. Proudly, a wide spectrum of NAA products is also available for your choice.

Features of Our Anti-E Services Including but Not Limited to

Blood matching for Rh and K antigens in patients with transfusion-dependent thalassemia could reduce the rate of RBC alloimmunization. RBC phenotyping should be performed in blood donors to determine the RBC antigenic profile among blood donors. Having worked in the field of NAA for many years, Creative Biolabs is able to provide our worldwide customers with high-quality anti-E antibody services for RBC phenotyping. If you are interested in the services we provided, please don’t hesitate to contact us for more information.

Reference

  1. Longo, Filomena, et al. "Ineffective erythropoiesis in β-thalassaemia: key steps and therapeutic options by drugs." International journal of molecular sciences 22.13 (2021): 7229.
For Research Use Only | Not For Clinical Use

Related Services:

Products:

Resource:

Applications:

Online Inquiry
Inquiry